Home > Insider Trading > Filing (0000935836-23-000621)

Filing Details

Accession Number:: 0000935836-23-000621
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2023-09-22 15:44:37
Reporting Period:: 2023-09-19

Accepted Time:: 2023-09-22 15:44:37
Original Submission Date:: 2023-09-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1811063	Nuvation Bio Inc.	NUVB	()	4/A

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1454385	Oleg Nodelman	357 Tehama Street #3 San Francisco CA 94103	Yes	No	No	No
1567938	Ecor1 Capital Fund, L.p.	357 Tehama Street #3 San Francisco CA 94103	Yes	No	No	No
1587114	Ecor1 Capital, Llc	357 Tehama Street #3 San Francisco CA 94103	Yes	No	No	No
1598292	Ecor1 Capital Fund Qualified, L.p.	357 Tehama Street #3 San Francisco CA 94103	Yes	No	No	No
1778011	Ecor1 Venture Opportunity Fund, Lp	357 Tehama Street #3 San Francisco CA 94103	Yes	No	No	No
1816370	Biotech Opportunity Gp, Llc	1370 Trancas Street, Suite 176 Napa CA 94558	Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2023-09-19	5,143,000	$1.26	12,504,675	No	4	P	Indirect	See Notes
Class A Common Stock	Acquisiton	2023-09-20	117,100	$1.36	12,621,775	No	4	P	Indirect	See Notes
Class A Common Stock	Acquisiton	2023-09-21	53,000	$1.36	12,674,775	No	4	P	Indirect	See Notes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Notes
No	4	P	Indirect	See Notes
No	4	P	Indirect	See Notes

Footnotes

EcoR1 Capital, LLC ("EcoR1") is the investment adviser to EcoR1 Capital Fund, L.P. ("Capital Fund"), EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund") and EcoR1 Venture Opportunity Fund, L.P. ("Venture Fund"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC ("Biotech") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
Qualified Fund is the record holder of these securities.
On 9/21/2023, the reporting persons filed a Form 4 (the "Original Form 4") that inadvertently identified the date of this transaction as 2/19/2023. As reported in this amendment, the date of this transaction was 9/19/2023. The Original Form 4 also inadvertently identified the date of the earliest transaction reported in the Original Form 4 as 2/19/2023. As reported in this amendment, the date of the earliest transaction was 9/19/2023.
The Original Form 4 inadvertently identified the date of this transaction as 2/20/2023. As reported in this amendment, the date of this transaction was 9/20/2023.
Original Form 4 inadvertently identified the date of this transaction as 2/21/2023. As reported in this amendment, the date of this transaction was 9/21/2023.